Supplementary Figure from Preclinical Development of [&lt;sup&gt;211&lt;/sup&gt;At]meta- astatobenzylguanidine ([&lt;sup&gt;211&lt;/sup&gt;At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma